Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain, Neuropharmacology, vol.50, pp.941-952, 2006. ,
Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3, Pharm. Res, vol.23, pp.697-704, 2006. ,
Regulation of alpha(1)-adrenoceptorlinked phosphoinositide metabolism in cultured glia: involvement of protein phosphatases and kinases, Cell. Signal, vol.15, pp.403-412, 2003. ,
Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonintransporter-deficient mice, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.18976-18981, 2008. ,
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin, Pharmacogenet. Genomics, vol.19, pp.497-504, 2009. ,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem. Pharmacol, vol.22, pp.3099-3108, 1973. ,
Regulation of organic cation transport, Pflugers Arch, vol.449, pp.423-441, 2005. ,
Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation, J. Am. Soc. Nephrol, vol.16, pp.1562-1570, 2005. ,
The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.8043-8048, 2009. ,
Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy, Pharmacol. Ther, vol.121, pp.89-99, 2009. ,
Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat, Naunyn Schmiedebergs Arch. Pharmacol, vol.354, pp.287-294, 1996. ,
Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)-and alpha(2)-adrenoceptors, Eur. J. Pharmacol, vol.415, pp.265-276, 2001. ,
Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog, Brain Res, vol.88, pp.257-268, 1991. ,
Synthesis and biological profile of the enantiomers of [4-(4-amino-6, 7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin-1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B-adrenoceptor antagonist, J. Med. Chem, vol.39, pp.4602-4607, 1996. ,
High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices, Mol. Pharmacol, vol.73, pp.50-61, 2008. ,
1?-Diisopropyl2, 4?-cyanine (disprocynium24), a potent uptake2 blocker, inhibits the renal excretion of catecholamines, Naunyn Schmiedebergs Arch. Pharmacol, vol.1, pp.115-125, 1997. ,
Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells, J. Biol. Chem, vol.272, pp.10408-10413, 1997. ,
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter, Nat. Neurosci, vol.1, pp.349-351, 1998. ,
Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells, Br. J. Pharmacol, vol.137, pp.910-918, 2002. ,
Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects, J. Histochem. Cytochem, vol.37, pp.1435-1442, 1989. ,
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3, Br. J. Pharmacol, vol.136, pp.829-836, 2002. ,
Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C, Biochemistry, vol.23, pp.5036-5041, 1984. ,
Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.28, pp.819-827, 2004. ,
The uptake of catecholamines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process, Br. J. Pharmacol, vol.25, pp.18-33, 1965. ,
Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene, Mol. Cell. Biol, vol.21, pp.5471-5477, 2001. ,
Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations, Mol. Cell. Biol, vol.23, pp.7902-7908, 2003. ,
Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications, Pharm. Res, vol.24, pp.1227-1251, 2007. ,
Changes in mRNA expression induced by sustained noradrenaline stimulation are different for alpha1-adrenoceptor subtypes in HEK293 cells, Clin. Exp. Pharmacol. Physiol, vol.29, pp.1084-1090, 2002. ,
The effect of DSP-4 (N-[2-chloroethyl]-N-ethyl-2bromobenzylamine) on monoamine oxidase activities in tissues of the rat, J. Pharm. Pharmacol, vol.33, pp.632-638, 1981. ,
The noradrenergic neurotoxin DSP-4 eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord, J. Neurosci, vol.9, pp.1481-1489, 1989. ,
Inhibition of acid secretion in gastric parietal cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-93, Biochem. Biophys. Res. Commun, vol.195, pp.608-615, 1993. ,
Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application, Pharmacol. Ther, vol.110, pp.135-370, 2006. ,
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents, J. Psychopharmacol, vol.14, pp.114-138, 2000. ,
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole, J. Pharmacol. Exp. Ther, vol.309, pp.903-920, 2004. ,
Transport of lamivudine [(?)-beta-L-2?, 3?-dideoxy-3?-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3, J. Pharmacol. Exp. Ther, vol.329, pp.252-261, 2009. ,
The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats, Brain Res, vol.1184, pp.260-269, 2007. ,
Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors, Naunyn Schmiedebergs Arch. Pharmacol, vol.358, pp.197-206, 1998. ,
Ligand-induced alpha2-adrenoceptor endocytosis: relationship to Gi protein activation, Biochem. Biophys. Res. Commun, vol.321, pp.226-233, 2004. ,
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1, 3-dimethyl-6, 7dihydrothianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptor, J. Med. Chem, vol.43, pp.765-768, 2000. ,
Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection, and biological activity, J. Med. Chem, vol.36, pp.4208-4213, 1993. ,
Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyaninetype inhibitors of extraneuronal monoamine transport, Naunyn Schmiedebergs Arch. Pharmacol, vol.354, pp.268-274, 1996. ,
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.5902-5907, 2003. ,
Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes, Xenobiotica, vol.38, pp.1252-1262, 2008. ,
The extraneuronal uptake and metabolism of catecholamines, Handbook of Experimental Pharmacology, vol.90, pp.279-319, 1988. ,
Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation, J. Neurosci, vol.24, pp.2846-2851, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-02008093
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice, J. Neurochem, vol.106, pp.1471-1482, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02008107
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet, Genomics, vol.18, pp.637-645, 2008. ,
Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C, Biochem. J, vol.294, issue.2, pp.335-337, 1993. ,
Differential effects of DSP-4 on noradrenaline axons in cerebral cortex and hypothalamus may reflect heterogeneity of noradrenaline uptake sites, Brain Res, vol.522, pp.308-314, 1990. ,
Cloning and functional expression of a human liver organic cation transporter, Mol. Pharmacol, vol.51, pp.913-921, 1997. ,
Functional characterization of the human organic cation transporter 2 variant p. 270Ala N Ser, Drug Metab. Dispos, vol.37, pp.1312-1318, 2009. ,
Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice, Mol. Cell. Biol, vol.21, pp.4188-4196, 2001. ,